Perkins Investment Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
Perkins Investment Management's NVS Position: Q1 2017 in Review
Perkins Investment Management reduced its Novartis (NVS) stake by 7.4% in Q1 2017, selling an estimated $458K and leaving 85,635 shares worth $5.7M. The position accounts for 0.07% of the portfolio, ranked #169.
Perkins Investment Management first reported a position in NVS in Q2 2013 and has held it in 16 quarters since. The position peaked at $22.9M in Q1 2014. 910 funds tracked by Wall St. Rank hold NVS as of Q1 2017.
- Perkins Investment Management held 85,635 shares of Novartis worth $5.7M as of Q1 2017.
- Perkins Investment Management sold 6,878 Novartis shares in Q1 2017, an estimated $458K.
- Novartis made up 0.07% of Perkins Investment Management's portfolio in Q1 2017, its #169 holding.
- Perkins Investment Management first reported a position in Novartis in Q2 2013 and has held it in 16 quarters since.
- Perkins Investment Management's Novartis position peaked at $22.9M in Q1 2014.
- 910 funds tracked by Wall St. Rank held Novartis as of Q1 2017.
Based on Perkins Investment Management's 13F filing for Q1 2017, filed 15 May 2017.